跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial
Approved
STANDARD
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b996040f07777add
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b996040f07777add
Product Name
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial
Artg Id
293593
Artg Name
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2019-05-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01013-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01755-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b996040f07777add
Type
Standard
Back to TGA Approvals